Assignee
MEDICINOVA INC
US·32 granted patents·28 pending applications·107 citations·filing 2003–2025
Top patents by PatentIndex Score
60 records- 0195US9314452B2Treatment of amyotrophic lateral sclerosis (ALS) with ibudilastMEDICINOVA INC·Filed 2014·Granted Apr 19, 2016·25 cites·12 claims
- 0290US9114136B2Treatment of progressive neurodegenerative disease with ibudilastMEDICINOVA INC·Filed 2012·Granted Aug 25, 2015·9 cites·11 claims
- 0389US11278531B2Combination of ibudilast and riluzole and methods of using sameMEDICINOVA INC·Filed 2020·Granted Mar 22, 2022·2 cites·8 claims
- 0489US7060854B2Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acidMEDICINOVA INC·Filed 2003·Granted Jun 13, 2006·17 cites·9 claims
- 0589US2025073213A1Treatment of progressive neurodegenerative disease with ibudilastMEDICINOVA INC·Filed 2024·Application pending·0 cites
- 0688US11446283B2Methods and dosing regimens using ibudilast and a second agent for cancer therapyMEDICINOVA INC·Filed 2020·Granted Sep 20, 2022·2 cites·17 claims
- 0788US10391085B2Methods of treating glioblastoma multiforme using ibudilastMEDICINOVA INC·Filed 2017·Granted Aug 27, 2019·4 cites·16 claims
- 0888US7728169B2Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of useMEDICINOVA INC·Filed 2008·Granted Jun 1, 2010·9 cites·19 claims
- 0987US11154540B2Methods of treating ophthalmic disease/disorder or injury with ibudilastMEDICINOVA INC·Filed 2019·Granted Oct 26, 2021·2 cites·20 claims
- 1087US10946071B2Combination of ibudilast and interferon-beta and methods of using sameMEDICINOVA INC·Filed 2019·Granted Mar 16, 2021·2 cites·17 claims
- 1185US11083713B2Treatment of progressive neurodegenerative disease with ibudilastMEDICINOVA INC·Filed 2019·Granted Aug 10, 2021·2 cites·10 claims
- 1285US7064146B2Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of useMEDICINOVA INC·Filed 2003·Granted Jun 20, 2006·17 cites·12 claims
- 1384US7153993B2Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acidMEDICINOVA INC·Filed 2005·Granted Dec 26, 2006·4 cites·9 claims
- 1483US10744123B2Methods and dosing regimens using ibudilast and a second agent for cancer therapyMEDICINOVA INC·Filed 2019·Granted Aug 18, 2020·3 cites·18 claims
- 1580US11944607B2Treatment of progressive neurodegenerative disease with ibudilastMEDICINOVA INC·Filed 2021·Granted Apr 2, 2024·0 cites·17 claims
- 1679US10258611B2Combination of ibudilast and riluzole and methods of using sameMEDICINOVA INC·Filed 2015·Granted Apr 16, 2019·2 cites·10 claims
- 1779US8962687B2Method of treating liver disordersMEDICINOVA INC·Filed 2014·Granted Feb 24, 2015·3 cites·40 claims
- 1877US8835499B2Method of treating non-alcoholic fatty liver disease and steatohepatitisMEDICINOVA INC·Filed 2012·Granted Sep 16, 2014·2 cites·16 claims
- 1976US9358217B2Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levelsMEDICINOVA INC·Filed 2014·Granted Jun 7, 2016·2 cites·29 claims
- 2070US12042485B2Methods of minimizing cancer metastasisMEDICINOVA INC·Filed 2022·Granted Jul 23, 2024·0 cites·20 claims
- 2169US12213966B2Methods of reducing plasma level of macrophage migratory inhibitory factor in patientsMEDICINOVA INC·Filed 2021·Granted Feb 4, 2025·0 cites·11 claims
- 2267US12171752B2Methods of treating post-COVID condition(s)MEDICINOVA INC·Filed 2023·Granted Dec 24, 2024·0 cites·20 claims
- 2367US11925625B2Methods of treating chemical gas exposureMEDICINOVA INC·Filed 2022·Granted Mar 12, 2024·0 cites·18 claims
- 2467US2015011581A1Treatment of progressive neurodegenerative disease with ibudilastMEDICINOVA INC·Filed 2014·Application pending·0 cites
- 2564US2024016729A1Injectable formulations of ibudilastMEDICINOVA INC·Filed 2023·Application pending·0 cites
- 2663US7786169B2Phenoxyalkycarboxylic acid derivatives in the treatment of ulcerative colitisMEDICINOVA INC·Filed 2008·Granted Aug 31, 2010·0 cites·9 claims
- 2763US2017020851A1Treatment of progressive neurodegenerative disease with ibudilastMEDICINOVA INC·Filed 2016·Application pending·0 cites
- 2863US2019247369A1Methods of suppressing myeloid-derived suppressor cells in patientsMEDICINOVA INC·Filed 2019·Application pending·0 cites
- 2963US2026069545A1Modified release formulations of ibudilastMEDICINOVA INC·Filed 2025·Application pending·0 cites
- 3062US12239620B2Methods to decrease triglyceride synthesis in the liverMEDICINOVA INC·Filed 2022·Granted Mar 4, 2025·0 cites·16 claims
- 3162US2017014390A1Treatment of progressive neurodegenerative disease with ibudilastMEDICINOVA INC·Filed 2016·Application pending·0 cites
- 3261US9012509B2Method of treating non-alcoholic steatohepatitisMEDICINOVA INC·Filed 2014·Granted Apr 21, 2015·0 cites·30 claims
- 3361US2020038382A1Methods of treating glioblastoma multiforme using ibudilastMEDICINOVA INC·Filed 2019·Application pending·0 cites
- 3460US12005049B2Methods of preventing cancer metastasisMEDICINOVA INC·Filed 2022·Granted Jun 11, 2024·0 cites·16 claims
- 3559US2015005385A1Method of treating non-alcoholic fatty liver disease and steatohepatitisMEDICINOVA INC·Filed 2014·Application pending·0 cites
- 3659US2021177812A1Methods of suppressing myeloid-derived suppressor cells in patientsMEDICINOVA INC·Filed 2020·Application pending·0 cites
- 3758US7365224B2Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of useMEDICINOVA INC·Filed 2005·Granted Apr 29, 2008·0 cites·12 claims
- 3858US2025221969A1Methods of reducing plasma level of macrophage migratory inhibitor factor in patientsMEDICINOVA INC·Filed 2025·Application pending·0 cites
- 3957US2015321989A1Method of treating idiopathic pulmonary fibrosisMEDICINOVA INC·Filed 2014·Application pending·0 cites
- 4057US2020030301A1Combination of ibudilast and riluzole and methods of using sameMEDICINOVA INC·Filed 2019·Application pending·0 cites
- 4155US2023090534A1Methods of treating glioblastoma multiforme using combination therapyMEDICINOVA INC·Filed 2022·Application pending·0 cites
- 4254US11865214B2Ibudilast oral formulations and methods of using sameMEDICINOVA INC·Filed 2020·Granted Jan 9, 2024·0 cites·10 claims
- 4354US7429617B2Phenoxyalkycarboxylic acid derivatives in the treatment of interstitial cystitisMEDICINOVA INC·Filed 2005·Granted Sep 30, 2008·0 cites·15 claims
- 4454US2015031769A1Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levelsMEDICINOVA INC·Filed 2014·Application pending·0 cites
- 4554US2014056999A1Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefromMEDICINOVA INC·Filed 2013·Application pending·0 cites
- 4653US2015051191A1Treatment of alcoholism using ibudilastMEDICINOVA INC·Filed 2014·Application pending·0 cites
- 4752US2018021275A1Method of treating idiopathic pulmonary fibrosisMEDICINOVA INC·Filed 2017·Application pending·0 cites
- 4851US8026282B2Phenoxyalkylcarboxylic acid derivatives in the treatment of irritable bowel syndromeMEDICINOVA INC·Filed 2010·Granted Sep 27, 2011·0 cites·8 claims
- 4949US2011117213A1Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefromMEDICINOVA INC·Filed 2010·Application pending·0 cites
- 5049US2014066513A1Methods for compositions for the treatment of irritable bowel syndromeMEDICINOVA INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MEDICINOVA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →